Form 4 for CNSP CNS Pharmaceuticals, Inc.
Accepted 2022-03-08 00:00:00 ET · period of report 2022-03-07 · accession 0001683168-22-001495 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-08 | 2022-03-07 | CNSP | Climaco John M | CEO, Dir | A - Grant | $0.28 | +35.0K | 940.3K | +4% | +$9,800 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-03-07 | A | A | 35,000 | $0.28 | 940,298 | D | — | — |